Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peptonic Medical enters collaboration agreement with ’1.6 & 2.6 Million Club’

Stockholm October 31, 2017 – Peptonic Medical (publ) (“Peptonic” or “Company”) today announced that it has signed a collaboration and sponsorship agreement with ’1.6 & 2.6 Million Club’. -          Peptonic Medical is a company focusing on women’s health and by this collaboration agreement we want to support research that can lead a better quality of life for women and more effective treatments of women specific diseases, says Johan Inborr, CEO of Peptonic Medcial. Generally, research and development within women’s health has had low priority. We want to change this. -          We are

Promore Pharma Signs Agreement with CRO PCG Clinical Services

STOCKHOLM, 31 October, 2017 -- Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that an agreement has been entered with PCG Clinical Services AB for the management of the LL-37 Phase IIb trial in patients with hard-to-heal leg ulcers. PCG was selected from several potential partners in a competitive process.Promore Pharma has signed an agreement with CRO PCG Clinical Services regarding the management of Promore Pharma’s LL-37 Phase IIb trial in patients with venous leg ulcers (VLU). The trial is anticipated to recruit 120 patients in Sweden

Aker ASA : Private placement in Aker BP ASA

Reference is made to Aker BP's ("Aker BP") stock exchange announcement today regarding a private placement (the "Private Placement") of 22,376,438 new shares in Aker BP.Aker Capital AS ("Aker"), a wholly-owned subsidiary of Aker ASA, subscribed for and was allocated 8,950,799 new shares in the Private Placement. Aker has entered into a share lending agreement with Nordea Bank AB (publ), filial i Norge ("Nordea"), and Aker BP, whereby Aker has agreed to lend 6,713,491 shares in Aker BP to Nordea to facilitate timely delivery of shares to subscribers in the Private Placement.

Change in number of votes and shares after completion of redemption of preference shares

According to previously disclosed information Balder has completed redemption of 10,000,000 preference shares. Redemption has resulted in a change in the number of shares and votes in Balder. The total number of shares as of 31 October 2017 is 180,000,000 shares, of which 11,229,432 are Class A shares and 168,770,568 are Class B shares. The total number of votes is 28,106,489, of which the Class A shares represent 11,229,432 votes and the Class B shares represent 16,877,057 votes. The information herein constitutes an announcement of a change of the number of shares and votes

Two Instalco companies to carry out installations in new police station in Rinkeby

The Instalco subsidiaries Rörgruppen and Ohmegi Elektro have been entrusted to participate in the construction of a new police station in Rinkeby in northern Stockholm. Rörgruppen’s heating and plumbing installations and Ohmegis electrical work are carried out under a subcontract for NCC, with Familjebostäder as customer. The total order value for Rörgruppen and Ohmegi amounts to approximately SEK 55 million.The assignment comprises the rebuilding of an existing residential property and an extension with a total area of approximately 14,500 square meters. The property will to a large extent

NeuroVive signs collaboration agreement with University of Florida for TBI biomarker development

Lund, Sweden, 31 October 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has signed a collaboration agreement with Kevin K.W. Wang, Ph.D., of the University of Florida to conduct biomarker research for NeuroVive’s traumatic brain injury (TBI) program. The research is aimed at developing alternative endpoints for the company’s clinical TBI program by analysing patient samples from the previously completed CHIC study.The research will evaluate the use of biofluid-based biomarkers in TBI drug development, which is increasingly

Orexo issues bonds of SEK 325 million and confirms fulfilment of condition under notice of early redemption

Uppsala, Sweden – October 31, 2017 – Orexo AB (publ.) (the “Company”) has issued a four-year senior unsecured bond loan in an amount of SEK 325 million, within a framework amount of SEK 500 million, due in November 2021. The bond loan has a floating interest rate of STIBOR 3m +4.50 per cent per year (quarterly payments in arrears). The net proceeds from the issue will mainly be used towards prepayment of the Company’s existing outstanding bond loan and for general corporate purposes. The issue date for the new bonds is expected to be 13 November 2017. The Company intends to list the new

NextCell Pharma updates on its situation in its fourth quarter report

NextCell Pharma AB ("NEXTCL", "NextCell") today releases its Q4 / year-end report (June 1st - August 31st  / September 1st - August 31st). This is the first quarterly report since the listing on Aktietorget. The company reports a loss of SEK -4,757,996 in its fourth quarter and a loss of SEK -13,245,206 for the entire financial year. The remaining cash at August 31st was approximately 16 MSEK.The perhaps most important event during the fourth quarter was the listing on Aktietorget on July 13th and the associated listing issue, which was subscribed to approximately 18 MSEK, corresponding to

Phase Holographic Imaging initiates CFO succession

Arne Bojesson has since PHI’s IPO in early 2014 been the CFO of PHI. During this time, he has successfully established well-functioning accounting routines, capable of handling PHI’s development. After nearly four years at PHI, Arne Bojesson, age 66, has decided to end his assignment. The company now initiates the recruitment of a successor to Bojesson, who will remain CFO until his position has been securely filled. In conjunction with leaving the Company, Bojesson has divested his holdings of 19 480 shares (0.17%) in PHI. “It has been a pleasure to work with Arne who with his long

AKER BP: NOK 4.1Bn PRIVATE PLACEMENT FULLY SUBSCRIBED

DISCLAIMER: This information is subject to disclosure under the Norwegian Securities Trading Act, Section 5-12. This announcement is not and does not form a part of any offer for sale of any securities, and is for release, publication or distribution, directly or indirectly, in the United States, or any other jurisdiction in which such distribution would be unlawful or would require registration  or other measures. Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S.

AKER BP: DIVIDEND RIGHTS IN CONTEMPLATED PRIVATE PLACEMENT

Reference is made to the announcement by Aker BP ASA (the “Company”) yesterday, 30 October 2017, at 16:38 CET, regarding a contemplated private placement (the “Private Placement”) of new shares in the Company. Investors who participate in the Private Placement are informed that the shares offered in the Private Placement will be delivered inclusive of the right to receive the cash dividend as announced by the Company yesterday, 30 October 2017, at 07:01 CET, of USD 0.185 per share, assuming that settlement of the Private Placement, by delivery and payment of shares, takes place on a

Changes in SCA’s Group Management

Due to approaching retirement, there will be changes in SCA’s Group Management.Mats Sandgren will leave his position as President of Business Area Forest as of April 1 2018. He will work on as senior advisor in SCA’s corporate staff. He will continue to report to Ulf Larsson, SCA’s President and CEO. Jonas Mårtensson, presently President of Business Area Wood, will take on the position as President of Business Area Forest as of April 1 2018 and at the same time leave his present position. Jerry Larsson, presently Manager of Obbola Papermill, will take on the position as President of

Cleantech Invest increases its holding in Nuuka Solutions to 48,1% through a share swap

Cleantech Invest Plc has signed a share swap agreement with Mikko Maja, the founder of Nuuka, as well as with three additional Nuuka co-founders. After the share swap, the holding of Cleantech Invest in Nuuka will increase to approx. 48,1%. The closing of the deal is expected to be on 29.11.2017 and may be adjusted somewhat depending on potential participation from other shareholders. Payment of the shares will be done through issuing a total of 143,100 new class A shares, offered to Mikko Maja and other co-founders for subscription. The subscription price will be paid by giving a

Nominating committee appointed at Paradox Interactive AB (publ) ahead of AGM 2018

In accordance with the decision by the Annual General Meeting, the members of the nominating committee of Paradox Interactive AB (publ) should be appointed by the three shareholders controlling the largest number of votes in Paradox Interactive AB (publ) at September 30, which desire to appoint a representative. In addition, the Chairman of the Board of Directors shall be a member of the nominating Committee. Paradox Interactive hereby announces that the nominating committee has now been appointed ahead of the Annual General Meeting in May 2018, and consists of the following members: Per

Change in number of shares and votes in Handicare

As a result of the new share issue, the bonus issue and the share issues-in-kind carried out by Handicare Group AB (publ) in connection with its initial public offering, the number of shares and votes in the company has changed since the first day of trading on Nasdaq Stockholm. As at October 31, 2017, there are in total 58,939,000 shares and votes in Handicare Group AB (publ).For further information, please contact: Boel Sundvall, Investor Relations Telephone: +46 723 747 487 E-mail: boel.sundvall@handicare.com This information is information that Handicare Group AB (publ) is

Interim Report Q3 2017

JANUARY 1 – SEPTEMBER 30, 2017(compared with the year-earlier period, continuing operations)  · Net sales increased 9% to SEK 12,422m (11,434) · Adjusted EBITDA improved 10% to SEK 2,683m (2,443) · The adjusted EBITDA margin was 21.6% (21.4) · Adjusted operating profit was SEK 1,838m (1,616) · Operating profit totaled SEK 1,725m (1,739) · Net profit for the period totaled SEK 1,278m (1,358) · Earnings per share amounted to SEK 1.82 (1.93) · Operating cash flow was SEK 1,431m (1,347)  A STRONG THIRD QUARTER The third quarter of 2017 was also SCA’s first

Swedbank issues its first Green Bond

On 30 October Swedbank successfully issued its inaugural Green Bond to accelerate the journey towards a more sustainable society and tackle climate change.Swedbank has recently established a Green Bond Framework and yesterday issued its inaugural EUR 500 million, 5 year Green bond. The proceeds from the Green Bond will be used to finance sustainable real-estate and renewable energy investments that reduces the carbon usage in society and contribute to several of the UN Sustainable Development Goals, as specified in Swedbank’s Green Bond Framework. Swedbank intends to be a regular

SBB, interim report January – September 2017: Earnings per share SEK 3.20, continued focus on cash flow, profitability and value creation

SAMHÄLLSBYGGNADSBOLAGET I NORDEN AB (PUBL): INTERIM PERIOD IN BRIEF •  Rental income increased to SEKm 954 (43). •  The net operating surplus increased to SEKm 620 (23). •  The net operating result increased, as a result of the improved net operating surplus, to SEKm 250 (0,2). •  The profit for the period increased to SEKm 2,047 (406), which correspond to an earnings per share of SEK 3.20 (N/A).     o Unrealized property value changes excluding building rights amounted to SEKm 1,774 (183).     o Unrealized value changes as a result of building rights amounted to SEKm 580 (

Newly-appointed Auramarine CEO announces actions towards agile, customer-facing services offering

Newly-appointed Auramarine  CEO Ole Skatka Jensen has announced the company’s new strategic direction, with a strong emphasis on combining engineering expertise with a hands-on, customer-first approach. Since his appointment in November 2016, Jensen has spearheaded several actions at Auramarine that have helped the company positively trend in a challenging business environment.   As result, the fuel supply solution provider is building a better understanding of the needs of its customers, widening its after sales offering, strengthening research and

HKScan to revise its operating profit outlook

HKScan Corporation                                   Stock Exchange Release 31 October 2017, at 9:00 EET   HKScan to revise its operating profit outlook HKScan Corporation estimates its comparable operating profit (EBIT) for 2017 to be at loss. HKScan previously estimated that its comparable operating profit (EBIT) for 2017 to stay below the previous year’s level (EUR 13.2 million). HKScan is currently ramping up the new poultry unit in Rauma, Finland. The reasons for the revised outlook is the higher than anticipated ramp up cost of the new Rauma unit and also the temporary

Fiskars financial reporting and Annual General Meeting in 2018

Fiskars CorporationStock Exchange ReleaseOctober 31, 2017 at 9:00 a.m. EETFiskars financial reporting and Annual General Meeting in 2018Fiskars Corporation will publish its financial reports in 2018 as follows:- Financial Statements Bulletin 2017: February 7, 2018- Interim report January–March: April 27, 2018- Half-year report January–June: August 1, 2018- Interim report January–September: October 31, 2018Annual Report 2017The Annual Report for 2017 will be published on Group’s website during week 8.Annual General MeetingFiskars Annual General Meeting will be held in

Raute Corporation - Interim Report January 1 - September 30, 2017

RAUTE CORPORATION INTERIM REPORT OCTOBER 31, 2017 AT 9:00 a.m.RAUTE CORPORATION - INTERIM REPORT JANUARY 1 - SEPTEMBER 30, 2017 - The Group’s net sales, EUR 109.0 million (MEUR 77.1), increased 41% on the comparison period. The order intake was EUR 94 million (MEUR 120).- Operating profit was EUR 8.3 million (MEUR 4.3), showing growth of 94% on the comparison period. The result before taxes was EUR 8.3 million (MEUR 3.9).- Earnings per share were EUR 1.52 (EUR 0.74).- Third-quarter net sales amounted to EUR 37.2 million and the operating result was EUR 4.2 million. Order intake was

Strong growth and continued investments

Press release(Third-quarter Interim Report July - September 2017 distributed as an appendix to this press release)  · Net sales increased 24% to MSEK 184.1 (148.2). · EBIT declined to MSEK 21.1 (22.3). · EBIT margin amounted to 11.5% (15.0). · Net income was MSEK 23.2 (17.6), of which MSEK 7.0 attributable to a deferred tax asset. · Earnings per share totaled SEK 2.32 (1.76), of which MSEK 0.70 attributable to a deferred tax asset. · The equity ratio was 47.8% (52.2). · New president and CEO for GARO, Carl-Johan Dalin assumed his new position on 4 September ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top